# optTMT: optimizing any experimental design to minimize false positives caused by TMT reporter ion interference

**Authors:** Marc-Antoine Gerault

PMC · DOI: 10.1093/bioadv/vbaf243 · 2025-10-01

## TL;DR

This paper introduces optTMT, a tool that helps proteomics researchers design experiments to reduce false positives caused by TMT reporter ion interference.

## Contribution

The novelty is a user-friendly optimization tool for minimizing TMT interference in experimental design.

## Key findings

- TMT reporter ion interference can lead to false positives in proteomics experiments.
- optTMT provides an optimized solution to reduce such interference through careful experimental planning.
- The tool is accessible via a Shiny app and R package for broad usability.

## Abstract

To enable multiplexing in large-scale proteomics experiment, TMT-plex isobaric tag has been the gold standard. However, tandem mass tag (TMT) reporter ion interference, also named cross-label isotopic impurity, can occur from manufacture level impurities and experimental error. Such interference increases the risk of false positive after differential analysis, even more so on high intensity peptide further leading to wrong conclusions. However, by planning the right experimental design beforehand these interferences can be minimized by solving an optimization problem. In this work, I present a user-friendly interface to allow the proteomics community to find any optimal TMT experimental designs.

The Shiny application is available as an executable file at https://zenodo.org/records/14883262 for Windows users and at https://marc-antoinegerault.shinyapps.io/TMT_optimization/. Code and documentation are freely available on github at https://github.com/mgerault/optTMT. The package is written in R and a vignette shows its use in an R command line workflow.

## Full-text entities

- **Genes:** RPS4Y1 (ribosomal protein S4 Y-linked 1) [NCBI Gene 6192] {aka RPS4Y, S4}, PCDH11Y (protocadherin 11 Y-linked) [NCBI Gene 83259] {aka PCDH-PC, PCDH22, PCDHX, PCDHY}, TBL1Y (transducin beta like 1 Y-linked) [NCBI Gene 90665] {aka DFNY2, TBL1}, KDM5D (lysine demethylase 5D) [NCBI Gene 8284] {aka HY, HYA, JARID1D, SMCY}, USP9Y (ubiquitin specific peptidase 9 Y-linked) [NCBI Gene 8287] {aka DFFRY, FAF-Y, SPGFY2}, UTY (ubiquitously transcribed tetratricopeptide repeat containing, Y-linked) [NCBI Gene 7404] {aka KDM6AL, KDM6C, UTY1}, CDY1B (chromodomain Y-linked 1B) [NCBI Gene 253175] {aka CDY}, EIF1AY (eukaryotic translation initiation factor 1A Y-linked) [NCBI Gene 9086] {aka eIF-4C}, CDY2B (chromodomain Y-linked 2B) [NCBI Gene 203611] {aka CDY}, NLGN4Y (neuroligin 4 Y-linked) [NCBI Gene 22829] {aka HNL4Y}, DDX3Y (DEAD-box helicase 3 Y-linked) [NCBI Gene 8653] {aka DBY}
- **Diseases:** Cancer (MESH:D009369)
- **Chemicals:** TMT (-), 129C (MESH:C000614984)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12975717/full.md

---
Source: https://tomesphere.com/paper/PMC12975717